SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 158.37 |
Enterprise Value ($M) | 135.80 |
Book Value ($M) | 242.10 |
Book Value / Share | 4.27 |
Price / Book | 0.65 |
NCAV ($M) | 238.04 |
NCAV / Share | 4.19 |
Price / NCAV | 0.67 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.20 |
Return on Assets (ROA) | -0.18 |
Return on Equity (ROE) | -0.18 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 29.31 |
Current Ratio | 29.31 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 248.04 |
Assets | 252.09 |
Liabilities | 10.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -62.38 |
Net Income | -49.59 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -43.10 |
Cash from Investing | 43.95 |
Cash from Financing | 0.51 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Star Irrevocable Trust #1 dated April 22, 2019 | 6.90 | 0.00 | |
13G/A | Light Irrevocable Trust #1 dated April 22, 2019 | 6.90 | 0.00 | |
13D/A | Logos Global Management LP | 7.50 | 50.49 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
102,691 | 211,256 | 48.61 | |
69,165 | 167,351 | 41.33 | |
79,966 | 194,038 | 41.21 | |
73,500 | 217,237 | 33.83 | |
(click for more detail) |
Similar Companies | |
---|---|
CYTK – Cytokinetics, Incorporated | DAWN – Day One Biopharmaceuticals, Inc. |
DNLI – Denali Therapeutics Inc. | DVAX – Dynavax Technologies Corporation |
EDIT – Editas Medicine, Inc. |
Financial data and stock pages provided by
Fintel.io